Prosecution Insights
Last updated: November 04, 2026

Mayinglong Massive Health Co. Ltd.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Mayinglong Massive Health Co. Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, MEYERS, ELIZABETH ANNE. The data identifies MEYERS, ELIZABETH ANNE as the busiest examiner.

The portfolio is active in a single distinct art unit, indicating a specific technical focus. MEYERS, ELIZABETH ANNE is responsible for the busiest examiner pending action. The concentration of the pending office action under a single examiner allows for a focused prosecution strategy in the Biotechnology & Pharmaceuticals sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MEYERS, ELIZABETH ANNE 1 21.1% +93.8%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18538047 COMPOSITION CONTAINING RECOMBINANT COLLAGEN WITH REPAIRING AND SOOTHING EFFECTS, EYE CREAM CONTAINING THE COMPOSITION AND PREPARATION METHOD THEREOR MEYERS, ELIZABETH ANNE —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18538047 COMPOSITION CONTAINING RECOMBINANT COLLAGEN WITH REPAIRING AND SOOTHING EFFECTS, EYE CREAM CONTAINING THE COMPOSITION AND PREPARATION METHOD THEREOR MEYERS, ELIZABETH ANNE —

Top Art Units

Art UnitApps
1617 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18538047 COMPOSITION CONTAINING RECOMBINANT COLLAGEN WITH REPAIRING AND SOOTHING EFFECTS, EYE CREAM CONTAINING THE COMPOSITION AND PREPARATION METHOD THEREOR MEYERS, ELIZABETH ANNE 1617 §103§112 Final Rejection — Pending Dec 13, 2023

Managing Mayinglong Massive Health Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Mayinglong Massive Health Co. Ltd. have?

Mayinglong Massive Health Co. Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Mayinglong Massive Health Co. Ltd. applications?

Elizabeth Anne Meyers has the most, with 1 of Mayinglong Massive Health Co. Ltd.'s pending office actions.

What technology area are Mayinglong Massive Health Co. Ltd.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month